To analyze the protein expression levels of different CDYL2 isoforms in human breast cancer cell lines and breast tumors, we conducted immunoblotting analyses using a commercial CDYL2 antibody (#ab183854, Abcam). This evidence concerns the gene CDYL2 and breast neoplasm.